NextGxDx, Inc. – Trademark Portfolio
Entity Type: 03
NextGxDx, Inc. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 7 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CONCERT GENETICS. The owner is based in Franklin, TN.
810 Crescent Centre Drive
Suite 280
Franklin, TN 37067
Showing of trademarks Trademarks
Trademark Classifications
NextGxDx, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does NextGxDx, Inc. have?
NextGxDx, Inc. has 7 U.S. trademarks filed with the USPTO. Of these, 1 registered, 6 cancelled.
What trademark classes does NextGxDx, Inc. file in?
NextGxDx, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 44 (Medical Services), Class 36 (Insurance & Financial). Class 42 covers scientific and technological services; industrial analysis and research services.
What are NextGxDx, Inc.'s most well-known trademarks?
NextGxDx, Inc.'s registered trademark portfolio includes well-known marks such as CONCERT GENETICS. These are among 1 currently registered trademark in the portfolio.
What is NextGxDx, Inc.'s trademark registration success rate?
NextGxDx, Inc. has a 14% trademark registration rate, with 1 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.